Announcement
06 Jun 2021
In July 2021, the U.S. Administration announced its decision to procure Merck’s investigational antiviral medicine for COVID-19 treatment.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
07 Jun 2021
Revocation date:
No revocation date
Updated: 06 Jun 2021
Public procurement, nes
In force
On 7 June 2021, the U.S. Administration announced that the government will procure 1.7 million courses of Merck’s investigational antiviral treatment, molnupiravir (MK-4482) for USD 1.2 billion should...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.